Table 2 Transplantation outcomes: engraftment and acute graft versus host disease
|  | Overall (n = 1711) | de novo (n = 1480) | sAML (n = 231) | P |
|---|---|---|---|---|
Engraftment HSCT | Â | Â | Â | Â |
Graft failure | 82 (5%) | 70 (4.9%) | 12 (5.6%) | 0.69 |
Engrafted | 1558 (95%) | 1354 (95.1%) | 204 (94.4%) | Â |
Mssing | 71 | 56 | 15 | Â |
cumulative incidence of PMN > 500, day 30 | 91.1% [89.5–92.4] | 86.6% [81.2–90.5] | 0.037 | |
Acute GVHD | Â | Â | Â | Â |
Grade I | 285 (17.4%) | 249 (17.5%) | 36 (16.7%) | Not done |
Grade II | 303 (18.5%) | 255 (18%) | 48 (22.3%) | Â |
Grade III | 103 (6.3%) | 93 (6.5%) | 10 (4.7%) | Â |
Grade IV | 38 (2.3%) | 34 (2.4%) | 4 (1.9%) | Â |
Present, grade unknown | 23 (1.4%) | 21 (1.5%) | 2 (0.9%) | Â |
No aGvHD present (Grade 0) | 883 (54%) | 768 (54.1%) | 115 (53.5%) | Â |
Missing | 76 | 60 | 16 | Â |